|
|
- 2019
Training patients for self‐administration of a new subcutaneous C1‐inhibitor concentrate for hereditary angioedemaDOI: 10.1002/nop2.194 Keywords: C1‐INH(SC), C1‐inhibitor, HAEGARDA, hereditary angioedema, prophylaxis, self‐administration, subcutaneous Abstract: The aim of this study was to provide recommendations for training patients with hereditary angioedema, based on nursing clinical trial experience, to self‐administer subcutaneous C1‐INH (C1‐INH[SC]) used as routine prophylaxis
|
